This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Failure and rejection of transplanted organs and tissues
ST19_FAILU_REJEC_TRANSPLANTED_ORGANS_TISSU
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
463 |
4. Check minimum number of eventsNone |
463 |
5. Include endpointsNone |
463 |
6. Filter based on genotype QC (FinnGen only) |
463 |
Control definitions (FinnGen only)
- Control exclude
- ST19_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T8
- Name in latin
- Insufficientia et rejectio organorum et textuum transplantatorum
Similar endpoints
↥List of similar endpoints to
Failure and rejection of transplanted organs and tissues
based on the number of shared cases.
Similar with more cases:
- Complications of surgical and medical care, not elsewhere classified
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 463 | 188 | 275 |
| Unadjusted period prevalence (%) | 0.10 | 0.06 | 0.12 |
| Median age at first event (years) | 52.88 | 51.14 | 54.06 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 441
- Matched controls
- 4409
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
127
Kela drug reimbursment
Transplant complication
981.7
323.0
367
22
L04AA06
ATC
mycophenolic acid; systemic
250.5
284.0
268
27
H02AB04
ATC
methylprednisolone; systemic
38.7
225.2
325
297
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
59.5
215.4
255
99
L04AD01
ATC
ciclosporin; systemic
166.6
206.8
206
23
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
204.6
180
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
47.4
194.0
242
110
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
219.9
186.5
182
14
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
458.8
181.7
170
6
Z94.0
ICD-10 Finland
Kidney transplant status
174.7
157.7
158
14
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
76.7
153.9
171
36
A05AA02
ATC
ursodeoxycholic acid; oral
85.1
145.4
159
29
XW000
NOMESCO Finland
Bone marrow biopsy
44.9
144.2
179
66
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
+∞
141.5
128
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
86.1
140.1
153
27
TK800
NOMESCO Finland
Hemodialysis
86.1
140.1
153
27
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
32.4
136.2
185
96
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
36.6
133.1
174
77
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
262.1
132.8
130
7
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
132.1
120
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
79.1
127.3
141
26
A11CC03
ATC
alfacalcidol; systemic
69.9
124.0
140
29
C03CA01
ATC
furosemide; systemic
11.9
112.1
254
450
ZX120
NOMESCO Finland
Intravenous
17.3
108.4
186
178
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
10.5
108.0
284
648
WW200
NOMESCO Finland
Immunization
34.6
107.1
141
59
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
13.1
106.5
216
300
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
12.6
104.5
217
314
WW500
NOMESCO Finland
Blood transfusion
34.3
104.0
137
57
A12AA04
ATC
calcium carbonate; oral
80.4
103.0
114
19
J05AB11
ATC
valaciclovir; oral
13.5
100.8
197
248
A49.9
ICD-10 Finland
Bacterial infection, unspecified
17.0
97.3
166
151
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
297.5
95.7
94
*
B03XA02
ATC
darbepoetin alfa; parenteral
60.7
94.9
110
24
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.9
92.7
338
1192
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
170.0
92.1
94
7
R4110
NOMESCO Finland
Physiotherapy
8.5
91.0
274
714
L04AA01
ATC
[U] ciclosporin; systemic
72.3
89.7
101
18
Z49.1
ICD-10 Finland
Extracorporeal dialysis
83.5
88.9
98
15
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
29.1
88.7
122
57
137
Kela drug reimbursment
Uraemia requiring dialysis
262.3
85.7
85
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
62.6
85.0
98
20
R50.9
ICD-10 Finland
Fever, unspecified
10.0
84.4
197
329
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
67.8
84.4
96
18
ZXD05
NOMESCO Finland
Urgent procedure
7.3
79.4
269
781
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
19.4
77.4
122
85
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
93.9
77.3
84
11
B05DA
ATC
Isotonic solutions
300.2
76.0
75
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
21.9
75.8
114
69
N18.0
ICD-10 Finland
End-stage renal disease
95.5
72.8
79
10
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
105.0
72.7
78
9
Z49.2
ICD-10 Finland
Other dialysis
276.4
70.5
70
*
H02AB09
ATC
hydrocortisone; systemic
33.9
68.7
90
33
N18.8
ICD-10 Finland
Other chronic renal failure
36.3
68.4
88
30
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
66.3
62
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
257.8
66.1
66
*
L03AA02
ATC
filgrastim; parenteral
33.6
64.8
85
31
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
+∞
64.1
60
*
B05DB
ATC
Hypertonic solutions
362.3
63.1
62
*
Y83.0
ICD-10 Finland
Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
63.0
59
*
ZXE00
NOMESCO Finland
One hour or less
5.6
62.2
290
1127
Z49.0
ICD-10 Finland
Preparatory care for dialysis
87.2
61.0
67
9
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
60.9
57
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
235.2
60.7
61
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
44.2
60.2
74
20
Z3231
NOMESCO Finland
Registered nurse
5.6
59.2
234
738
M04AA01
ATC
allopurinol; systemic
8.8
59.0
140
220
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
6.2
58.4
196
505
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
169.7
57.4
59
*
ZX108
NOMESCO Finland
Inhalation
74.5
57.0
64
10
Z2446
NOMESCO Finland
Social worker
11.0
56.4
115
137
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
19.9
55.9
86
53
C08CA01
ATC
amlodipine; oral
5.2
55.8
241
824
V03AE01
ATC
polystyrene sulfonate; oral
66.5
55.2
63
11
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
6.6
54.9
167
373
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
16.1
54.9
92
71
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
42.0
54.8
68
19
ZXE20
NOMESCO Finland
More than three and less than five hours
7.4
54.4
148
283
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
19.2
52.1
81
51
J02AC03
ATC
voriconazole; systemic
153.3
52.1
54
*
ZXE10
NOMESCO Finland
More than one and less than three hours
4.8
51.7
256
983
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
104.5
51.1
55
6
Z2221
NOMESCO Finland
Medical doctor
5.0
50.8
220
733
ZXA00
NOMESCO Finland
Right side
5.0
49.3
207
662
J01MA12
ATC
levofloxacin; systemic
5.9
47.4
155
369
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
8.2
46.4
113
178
A04AA01
ATC
ondansetron; systemic, rectal
10.2
46.2
97
119
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
45.5
46.0
56
14
V03AE02
ATC
sevelamer; oral
134.2
45.7
48
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.3
45.6
169
463
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
51.1
45.3
54
12
TK820
NOMESCO Finland
Peritoneal dialysis
249.8
44.8
45
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.5
44.8
106
159
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
107.4
44.8
48
5
Z3226
NOMESCO Finland
Physiotherapist
5.3
44.7
166
454
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
44.5
206
709
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
4.2
44.5
278
1268
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
471.9
44.0
43
*
L04AX01
ATC
azathioprine; systemic
12.5
42.9
80
77
196
Kela drug reimbursment
Paricalcitol and cinacalcet
124.9
42.6
45
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
162.4
42.6
44
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.9
42.1
168
491
A02BC02
ATC
pantoprazole; systemic
4.4
41.7
345
1979
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.5
41.7
194
661
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
9.5
41.4
90
116
KA1AE
NOMESCO Finland
Kidney ultrasound examination
21.3
41.0
61
33
B03XA01
ATC
erythropoietin; parenteral
49.9
41.0
49
11
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
7.7
39.7
99
159
205
Kela drug reimbursment
Chronic hypertension
4.6
39.3
170
533
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
62.4
39.1
45
8
J05AB01
ATC
aciclovir; systemic
4.7
38.3
155
452
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
207.3
37.4
38
*
TK810
NOMESCO Finland
Hemofiltration
109.7
37.4
40
*
ZXD10
NOMESCO Finland
Scheduled procedure
3.8
37.4
243
1084
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
32.2
37.3
49
17
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
87.8
36.5
40
5
V03AE03
ATC
lanthanum carbonate; oral
106.7
36.4
39
*
WW409
NOMESCO Finland
Other aferesis
138.2
36.3
38
*
A07AA02
ATC
nystatin; oral
9.3
36.0
78
99
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
9.5
35.9
77
96
J01MA14
ATC
moxifloxacin; systemic
6.9
35.8
97
174
TGC00
NOMESCO Finland
Bronchial lavation
17.0
35.5
57
38
ZXA10
NOMESCO Finland
Bilateral
5.0
35.3
132
350
A41.9
ICD-10 Finland
Sepsis, unspecified
17.2
35.0
56
37
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
17.8
34.9
55
35
5AB14
NOMESCO Finland
NA
100.7
34.3
37
*
ZXA05
NOMESCO Finland
Left side
3.9
33.7
175
632
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
7.4
33.7
85
137
N02AX02
ATC
tramadol; systemic, rectal
3.5
33.6
244
1156
GD1AD
NOMESCO Finland
Thorax CT examination
10.6
33.5
67
73
C07AB02
ATC
metoprolol; systemic
4.8
33.5
130
356
N02AA05
ATC
oxycodone; systemic
5.5
32.7
108
247
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.5
32.5
133
383
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
24.9
32.1
45
20
C08CA02
ATC
felodipine; oral
7.1
31.6
82
137
WX892
NOMESCO Finland
Monitored bed care
6.6
31.2
86
156
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
172.0
31.1
32
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
30.9
212
941
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
7.2
30.6
78
127
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
6.6
30.3
83
149
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
28.1
30.3
41
16
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
6.7
30.1
82
146
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
114.7
30.1
32
*
WX002
NOMESCO Finland
Sedation and analgesia
4.0
30.0
142
464
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
4.2
29.8
132
406
H26.3
ICD-10 Finland
Drug-induced cataract
61.2
29.6
34
6
D11AH01
ATC
tacrolimus; topical
30.4
29.4
39
14
D64.9
ICD-10 Finland
Anaemia, unspecified
7.1
29.4
76
126
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
7.3
29.0
73
116
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
52.4
28.8
34
7
WW400
NOMESCO Finland
Plasmaferesis
299.5
28.1
28
*
J01MA02
ATC
ciprofloxacin; systemic
3.2
28.0
214
1008
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
28.7
27.6
37
14
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.9
27.5
100
251
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
+∞
27.4
26
*
N19
ICD-10 Finland
Unspecified kidney failure
17.5
27.3
43
27
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.4
27.3
62
84
H05BX01
ATC
cinacalcet; oral
80.4
27.1
30
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
22.4
27.0
39
19
K65.0
ICD-10 Finland
Acute peritonitis
36.7
26.9
34
10
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
7.8
26.7
64
94
RS220
NOMESCO Finland
NA
21.2
26.6
39
20
JN3AD
NOMESCO Finland
Abdominal CT examination
6.6
26.5
72
127
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
8.3
26.2
60
82
JN4BD
NOMESCO Finland
Extensive body CT
4.9
25.9
92
224
TPH07
NOMESCO Finland
Cathetrisation of artery
5.4
25.9
84
185
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
7.2
25.6
65
104
C09AA02
ATC
enalapril; systemic
4.0
25.5
116
360
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
+∞
25.2
24
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
7.4
25.2
62
95
321
Kela drug reimbursment
Paricalcitol and cinacalcet
74.4
25.1
28
*
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
74.4
25.1
28
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
5.0
25.1
87
206
B02.9
ICD-10 Finland
Zoster without complication
8.4
24.8
56
75
A02BC01
ATC
omeprazole; systemic
3.2
24.5
161
665
3AC01
NOMESCO Finland
NA
31.2
24.4
32
11
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
20.5
24.3
36
19
Z94.1
ICD-10 Finland
Heart transplant status
59.6
24.3
28
5
J01FF01
ATC
clindamycin; systemic
3.2
24.3
165
696
N17.9
ICD-10 Finland
Acute renal failure, unspecified
10.1
24.2
49
54
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
+∞
24.2
23
*
XF400
NOMESCO Finland
ECG with 12 standard connections
3.8
24.1
116
376
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
6.3
24.0
67
122
J02AC04
ATC
posaconazole; systemic
132.2
23.8
25
*
UJF30
NOMESCO Finland
Ileoscopy through colon
5.0
23.7
81
188
ZX112
NOMESCO Finland
Subcutaneous
15.2
23.6
39
28
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.1
23.3
54
75
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
38.7
23.3
29
8
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.7
23.1
118
400
JN4AD
NOMESCO Finland
Body CT examination
6.2
23.0
65
120
WX402
NOMESCO Finland
General anaesthesia
3.6
23.0
121
420
RD210
NOMESCO Finland
NA
14.1
22.9
39
30
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
6.2
22.8
64
117
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.4
22.8
56
85
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
242.0
22.8
23
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
126.6
22.8
24
*
Z3229
NOMESCO Finland
Other healthcare associate professional
5.2
22.7
74
163
ZXE40
NOMESCO Finland
More than seven and less than nine hours
12.8
22.5
40
34
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
22.4
135
518
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.9
22.3
191
930
GD1LA
NOMESCO Finland
GD
30.9
22.1
29
10
Z96.1
ICD-10 Finland
Presence of intraocular lens
5.4
22.1
70
149
C07AG02
ATC
carvedilol; oral
7.2
22.0
55
86
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
7.5
21.9
53
79
2AX04
NOMESCO Finland
NA
230.9
21.8
22
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
230.9
21.8
22
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
15.0
21.7
36
26
SAA03
NOMESCO Finland
Extended examination of mouth
2.7
21.7
227
1243
5BA08
NOMESCO Finland
NA
45.8
21.6
26
6
Z94.7
ICD-10 Finland
Corneal transplant status
45.8
21.6
26
6
WX872
NOMESCO Finland
Intensive care
6.9
21.5
55
89
C02AC05
ATC
moxonidine; oral
7.6
21.2
51
75
Z94.4
ICD-10 Finland
Liver transplant status
63.2
21.1
24
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
39.3
21.0
26
7
C07AB07
ATC
bisoprolol; oral
2.7
21.0
217
1170
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
219.9
20.8
21
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
115.5
20.8
22
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
15.2
20.7
34
24
H26.2
ICD-10 Finland
Complicated cataract
27.0
20.7
28
11
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.3
20.3
80
214
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.1
20.2
135
552
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
60.5
20.1
23
*
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
20.1
128
507
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.3
20.0
64
137
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.3
20.0
64
137
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.5
20.0
62
128
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
+∞
19.9
19
*
T86.4
ICD-10 Finland
Liver transplant failure and rejection
+∞
19.9
19
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
30.6
19.9
26
9
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
26.0
19.8
27
11
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
26.0
19.8
27
11
D07AB08
ATC
desonide; topical
4.4
19.6
76
199
C90.0
ICD-10 Finland
Multiple myeloma
21.3
19.3
28
14
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.2
19.2
78
214
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
19.8
18.9
28
15
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
+∞
18.9
18
*
T86.2
ICD-10 Finland
Heart transplant failure and rejection
+∞
18.9
18
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
73.2
18.9
21
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
198.0
18.7
19
*
L04AA05
ATC
[U] tacrolimus; systemic
198.0
18.7
19
*
RS221
NOMESCO Finland
NA
12.6
18.6
33
28
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
11.8
18.5
34
31
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
9.0
18.4
39
47
B07.9
ICD-10 Finland
Verruca simplex
7.0
18.4
46
72
B01AB10
ATC
tinzaparin; parenteral
5.6
18.2
55
110
KBV00
NOMESCO Finland
Insertion of stent into ureter
34.5
18.1
23
7
C08CA13
ATC
lercanidipine; oral
3.9
18.1
80
236
SPAT1255
SPAT
Intravenous administration of medicine
5.5
18.1
55
111
B99
ICD-10 Finland
Other and unspecified infectious diseases
14.5
18.0
30
22
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
21.2
17.9
26
13
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.9
17.9
51
95
N16.5*T86.9
ICD-10 Finland
Renal tubulo-interstitial disorder in transplant rejection
+∞
17.8
17
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
17.8
17
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
7.3
17.8
43
64
1CX01
NOMESCO Finland
NA
187.2
17.6
18
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
187.2
17.6
18
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
187.2
17.6
18
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
187.2
17.6
18
*
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
187.2
17.6
18
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
17.9
17.6
27
16
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.7
17.5
41
58
TAB00
NOMESCO Finland
Lumbar puncture
6.2
17.5
48
85
H04.10
ICD-10 Finland
Dry eye syndrome
4.2
17.5
71
194
B01AB05
ATC
enoxaparin; parenteral
2.7
17.5
143
655
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.4
17.3
264
1694
XPX08
NOMESCO Finland
Intraoperative flow measurement
52.2
17.1
20
*
TPH00
NOMESCO Finland
Phlebotomy
52.2
17.1
20
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.9
17.1
76
225
R4190
NOMESCO Finland
Nutritional therapy
6.7
17.0
44
72
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.9
16.9
57
129
212
Kela drug reimbursment
Gout
13.4
16.9
29
23
H02AB06
ATC
prednisolone; systemic
2.4
16.9
222
1315
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
36.6
16.8
21
6
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
17.2
16.8
26
16
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
93.7
16.7
18
*
J02AC01
ATC
fluconazole; systemic
2.5
16.5
182
979
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
16.2
16.4
26
17
D70.89
ICD-10 Finland
Neutropenic splenomegaly
17.6
16.3
25
15
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
17.6
16.3
25
15
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
16.2
70
202
6BA02
NOMESCO Finland
NA
25.6
16.2
22
9
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
49.5
16.1
19
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.7
16.1
47
90
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
8.5
16.1
35
44
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.3
16.1
63
166
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
5.4
16.1
49
99
A41.8
ICD-10 Finland
Other specified sepsis
16.5
15.9
25
16
Z94.2
ICD-10 Finland
Lung transplant status
62.4
15.9
18
*
ZX121
NOMESCO Finland
Central venous catheter
34.8
15.9
20
6
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
20.1
15.7
23
12
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
14.5
15.7
26
19
Z99.2
ICD-10 Finland
Dependence on renal dialysis
165.6
15.6
16
*
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
165.6
15.6
16
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.2
15.5
49
103
ZX090
NOMESCO Finland
Other technic of radiotherapy
8.0
15.5
35
47
WX110
NOMESCO Finland
Local anesthesy
2.4
15.5
333
2464
B01AA03
ATC
warfarin; systemic
3.2
15.5
91
335
U14
ICPC
Kidney symptom/complaint
13.7
15.4
26
20
C10AA03
ATC
pravastatin; oral
4.9
15.3
51
114
J01DB01
ATC
cefalexin; oral
2.7
15.2
372
2931
WX610
NOMESCO Finland
Patient controlled analgesia
46.7
15.2
18
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.3
15.1
228
1414
A07EA06
ATC
budesonide; oral, local oral
6.7
14.9
38
61
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
17.2
14.9
23
14
E0000UV
ATC
NA
2.3
14.9
195
1130
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.4
14.8
45
91
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.5
14.7
44
87
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
14.7
14
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
+∞
14.7
14
*
J05AX18
ATC
letermovir; oral
+∞
14.7
14
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
154.9
14.5
15
*
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
37.4
14.5
18
5
XCK10
NOMESCO Finland
Photography of fundus of eye
3.8
14.5
64
188
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.4
14.5
146
741
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.9
14.5
48
107
A07AA09
ATC
vancomycin; oral
17.7
14.4
22
13
H25.1
ICD-10 Finland
Senile nuclear cataract
3.1
14.4
86
319
I50.9
ICD-10 Finland
Heart failure, unspecified
4.2
14.4
57
152
XF602
NOMESCO Finland
Bloodpressure monitoring
23.2
14.3
20
9
WX882
NOMESCO Finland
High dependency care
6.8
14.3
36
57
E87.5
ICD-10 Finland
Hyperkalaemia
15.1
14.2
23
16
SPAT1262
SPAT
Handing over of treatment supplies
2.9
14.2
100
411
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
3.1
14.1
86
321
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.5
14.0
51
125
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
9.0
14.0
29
34
NHQ40
NOMESCO Finland
Amputation of toe
12.0
14.0
25
22
K65.9
ICD-10 Finland
Peritonitis, unspecified
55.2
13.9
16
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
14.2
13.9
23
17
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
6.7
13.8
35
56
S01ED01
ATC
timolol; ophthalmic
8.4
13.8
30
38
WZC30
NOMESCO Finland
Teaching
3.2
13.8
80
288
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
77.6
13.7
15
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
77.6
13.7
15
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.0
13.6
56
155
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
26.7
13.5
18
7
M05BA04
ATC
alendronic acid; oral
5.1
13.5
43
92
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
10.2
13.4
26
27
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
5.6
13.4
39
75
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.7
13.3
101
433
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
41.4
13.2
16
*
TPX15
NOMESCO Finland
Removal of vascular injection port
41.4
13.2
16
*
A10AE04
ATC
insulin glargine; parenteral
3.5
13.2
65
209
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
17.4
13.1
20
12
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
29.4
13.0
17
6
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.8
13.0
44
100
N17.8
ICD-10 Finland
Other acute renal failure
23.4
13.0
18
8
NF1AA
NOMESCO Finland
Hip X-ray examination
4.5
13.0
46
110
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
8.9
13.0
27
32
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.3
12.9
49
125
GDG10
NOMESCO Finland
Bilateral transplantation of lung
51.6
12.9
15
*
H3603, E103
ICD-10 Finland
NA
12.8
12.7
22
18
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.7
12.7
29
40
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
72.0
12.7
14
*
RS230
NOMESCO Finland
NA
72.0
12.7
14
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.8
12.6
55
160
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
12.6
12
*
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
12.6
12
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
+∞
12.6
12
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
20.8
12.5
18
9
WYA20
NOMESCO Finland
Home visit
25.2
12.5
17
7
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
12.5
91
379
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
133.6
12.5
13
*
UJF32
NOMESCO Finland
Coloscopy
2.5
12.5
118
572
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.8
12.4
28
38
H02AB02
ATC
dexamethasone; systemic
3.5
12.4
60
190
ZX100
NOMESCO Finland
Oral
14.9
12.4
20
14
I50.0
ICD-10 Finland
Congestive heart failure
6.0
12.4
34
61
N05BA06
ATC
lorazepam; systemic, sublingual
5.4
12.3
37
74
N05CF01
ATC
zopiclone; oral
2.3
12.3
147
799
ZX197
NOMESCO Finland
NA
38.7
12.3
15
*
XG410
NOMESCO Finland
Flow-volume spirometry
5.7
12.2
35
66
C03DA01
ATC
spironolactone; oral
3.7
12.1
53
155
B01AB04
ATC
dalteparin; parenteral
5.2
12.0
37
76
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
12.0
54
161
C10AA01
ATC
simvastatin; oral
2.1
12.0
171
1004
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
48.0
11.9
14
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
48.0
11.9
14
*
EBA10
NOMESCO Finland
Surgical removal of tooth
2.9
11.8
79
313
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.7
11.7
40
92
WX140
NOMESCO Finland
Parabulbar anesthesy
6.0
11.7
32
57
V03AG01
ATC
sodium cellulose phosphate; systemic
31.0
11.7
15
5
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
7.5
11.7
27
38
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
5.3
11.7
35
70
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
66.8
11.7
13
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
66.8
11.7
13
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
66.8
11.7
13
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
23.6
11.6
16
7
153
Kela drug reimbursment
Lenalidomid
23.6
11.6
16
7
C08CA03
ATC
isradipine; systemic
23.6
11.6
16
7
UKC02
NOMESCO Finland
Cystoscopy
2.8
11.6
78
311
187
Kela drug reimbursment
MPA
+∞
11.5
11
*
J01XX08
ATC
linezolid; systemic
+∞
11.5
11
*
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
+∞
11.5
11
*
5AD01
NOMESCO Finland
NA
+∞
11.5
11
*
WX740
NOMESCO Finland
Nitrogen oxide therapy
123.1
11.5
12
*
3604
FHL
Penetration of the cornea
123.1
11.5
12
*
7151
FHL
Kidney transplantation
123.1
11.5
12
*
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
123.1
11.5
12
*
WX199
NOMESCO Finland
Other local analgesia
8.7
11.4
24
29
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
12.3
11.4
20
17
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
7.6
11.4
26
36
ED1AA
NOMESCO Finland
Mandipular X-ray examination
15.6
11.4
18
12
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
36.0
11.3
14
*
XF612
NOMESCO Finland
Measurement of central venous pressure
36.0
11.3
14
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
8.0
11.3
25
33
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.2
11.3
63
221
K06.18
ICD-10 Finland
Another gingival hyperplasia
17.6
11.3
17
10
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
17.6
11.3
17
10
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
13.2
11.2
19
15
H43.1
ICD-10 Finland
Vitreous haemorrhage
8.4
11.2
24
30
K05.31
ICD-10 Finland
Periodontitis pronounced
3.2
11.2
62
215
C09AA05
ATC
ramipril; oral
2.4
11.2
108
523
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.3
11.2
34
69
EB1WA
NOMESCO Finland
NA
25.8
11.2
15
6
M87.0
ICD-10 Finland
Idiopathic aseptic necrosis of bone
25.8
11.2
15
6
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
25.8
11.2
15
6
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.9
11.2
36
78
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.3
11.2
41
102
M01AE01
ATC
ibuprofen; systemic, rectal
0.5
11.1
285
3508
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.3
11.0
41
103
R11
ICD-10 Finland
Nausea and vomiting
3.6
11.0
51
156
J04AB02
ATC
rifampicin; systemic
44.5
11.0
13
*
NGQ20
NOMESCO Finland
Amputation of lower leg
44.5
11.0
13
*
TQW99
NOMESCO Finland
Other minor procedure on skin
5.1
10.9
34
71
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
11.0
10.9
20
19
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
28.8
10.8
14
5
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.5
10.7
51
159
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
22.1
10.7
15
7
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
22.1
10.7
15
7
WW300
NOMESCO Finland
Transfer of autologic stem cells
22.1
10.7
15
7
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
61.5
10.7
12
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
61.5
10.7
12
*
A10AA02
ATC
NA
5.7
10.6
30
56
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
9.5
10.6
21
23
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
4.9
10.6
34
74
H26.4
ICD-10 Finland
After-cataract
4.4
10.5
38
93
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
5.0
10.5
33
70
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
4.6
10.5
36
84
5AB01
NOMESCO Finland
NA
112.6
10.5
11
*
2AX05
NOMESCO Finland
NA
+∞
10.5
10
*
TQW80
NOMESCO Finland
Local dermatologic skincare
6.9
10.3
25
38
L04AX04
ATC
lenalidomide; oral
24.0
10.3
14
6
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.2
10.2
54
183
E86
ICD-10 Finland
Volume depletion
9.5
10.1
20
22
WW402
NOMESCO Finland
Leucoferesis
41.1
10.0
12
*
B73
ICPC
Leukaemia
41.1
10.0
12
*
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
41.1
10.0
12
*
7AX01
NOMESCO Finland
NA
41.1
10.0
12
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
6.6
10.0
25
40
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
12.6
9.9
17
14
C08CA05
ATC
nifedipine; systemic
3.9
9.9
40
109
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
11.0
9.9
18
17
3A064
NOMESCO Finland
NA
26.7
9.9
13
5
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
26.7
9.9
13
5
XX4BW
NOMESCO Finland
NA
26.7
9.9
13
5
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
20.6
9.9
14
7
A10AA01
ATC
NA
5.6
9.8
28
53
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.8
9.8
41
115
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.8
9.7
16
12
JN4CD
NOMESCO Finland
Very extensive body CT
5.5
9.7
28
54
A06AD11
ATC
lactulose; oral
2.9
9.7
60
226
N25.0
ICD-10 Finland
Renal osteodystrophy
56.2
9.7
11
*
H05BX02
ATC
paricalcitol; systemic
56.2
9.7
11
*
TCG10
NOMESCO Finland
Removal of sutures from cornea
56.2
9.7
11
*
AA1AD
NOMESCO Finland
CT of head and brain
2.3
9.7
101
508
H18.6
ICD-10 Finland
Keratoconus
15.5
9.6
15
10
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
15.5
9.6
15
10
K05.30
ICD-10 Finland
Periodontitis complex
2.6
9.6
72
305
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.6
9.5
32
73
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
7.8
9.5
21
28
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.7
9.5
66
267
KAC00
NOMESCO Finland
Nephrectomy
18.0
9.5
14
8
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
102.1
9.4
10
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
102.1
9.4
10
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
102.1
9.4
10
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
30.7
9.4
12
*
A10AE05
ATC
insulin detemir; parenteral
3.8
9.4
40
114
C02EA02
ATC
NA
7.2
9.4
22
32
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
5.3
9.4
28
56
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
+∞
9.4
9
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
9.4
9
*
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
+∞
9.4
9
*
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
4.9
9.4
30
65
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
6.7
9.4
23
36
S97
ICPC
Chronic ulcer skin
4.7
9.4
31
70
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.3
9.3
24
40
J01CA04
ATC
amoxicillin; systemic
2.2
9.3
365
3045
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.4
9.3
33
80
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
14.1
9.2
15
11
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
6.5
9.2
23
37
WX202
NOMESCO Finland
Supraclavicular plexus blockade
8.6
9.2
19
23
201
Kela drug reimbursment
Chronic cardiac insufficiency
5.1
9.2
28
58
A01AB04
ATC
amphotericin B; local oral
5.1
9.2
28
58
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.2
9.1
49
168
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
11.8
9.1
16
14
N02BE01
ATC
paracetamol; systemic, rectal
2.1
9.1
360
2993
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
10.3
9.1
17
17
Z51.5
ICD-10 Finland
Palliative care
4.3
9.1
33
82
N083, E102
ICD-10 Finland
NA
37.5
9.1
11
*
742
NOMESCO Finland
NA
37.5
9.1
11
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
37.5
9.1
11
*
RJ414
NOMESCO Finland
NA
37.5
9.1
11
*
L57.0
ICD-10 Finland
Actinic keratosis
3.3
9.1
45
146
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
19.1
9.0
13
7
TKC20
NOMESCO Finland
Catheterisation of bladder
3.9
9.0
36
98
A28
ICPC
Limited function/disability NOS
2.9
8.9
56
213
ZX114
NOMESCO Finland
Intramuscular
12.9
8.9
15
12
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.8
8.9
37
104
103
Kela drug reimbursment
Diabetes, insulin-treated
2.1
8.7
115
636
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
51.0
8.7
10
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
51.0
8.7
10
*
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
51.0
8.7
10
*
A01AB09
ATC
miconazole; local oral
3.3
8.7
44
145
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.5
8.7
18
22
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.7
8.6
58
231
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
16.7
8.6
13
8
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
28.1
8.5
11
*
M01AH05
ATC
etoricoxib; oral
0.5
8.5
132
1958
M10.9
ICD-10 Finland
Gout, unspecified
3.9
8.5
34
93
H18.1
ICD-10 Finland
Bullous keratopathy
91.7
8.4
9
*
K65.8
ICD-10 Finland
Other peritonitis
91.7
8.4
9
*
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
91.7
8.4
9
*
3718X
ICD-9 Finland
Corneal opacity and other disorders of cornea, Other corneal disorders
91.7
8.4
9
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
6.0
8.4
22
38
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
+∞
8.4
8
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
8.4
8
*
4AA09
NOMESCO Finland
NA
+∞
8.4
8
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.7
8.3
16
17
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.0
8.3
48
174
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
14.8
8.2
13
9
A12BA01
ATC
potassium chloride; oral
5.9
8.2
22
39
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
7.8
8.2
18
24
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
7.8
8.2
18
24
A46
ICD-10 Finland
Erysipelas
2.5
8.2
64
276
ZY010
NOMESCO Finland
Hospital outpatient
3.7
8.2
35
101
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.0
8.2
47
169
TFJ02
NOMESCO Finland
Muscle biopsy of heart
34.0
8.1
10
*
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
34.0
8.1
10
*
C09CA01
ATC
losartan; oral
2.1
8.1
97
517
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
22.5
8.0
11
5
YNB10
NOMESCO Finland
Collection of stem cells for transplant
22.5
8.0
11
5
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
4.7
8.0
26
58
G04CA02
ATC
tamsulosin; oral
2.1
8.0
96
512
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.2
8.0
82
408
N03AX16
ATC
pregabalin; oral
2.1
7.9
96
513
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
6.3
7.9
20
33
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.8
7.9
170
1127
RS222
NOMESCO Finland
NA
11.1
7.8
14
13
C10AA04
ATC
fluvastatin; oral
3.2
7.8
40
133
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
9.7
7.8
15
16
G04BE03
ATC
sildenafil; oral
9.7
7.8
15
16
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.7
7.8
21
38
E89.4
ICD-10 Finland
Postprocedural ovarian failure
45.8
7.7
9
*
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
45.8
7.7
9
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
3.9
7.7
30
80
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.3
7.7
74
356
C08DB01
ATC
diltiazem; oral
5.1
7.7
23
47
C10AA05
ATC
atorvastatin; oral
1.9
7.7
148
939
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.1
7.7
41
141
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
6.9
7.7
18
27
C02CA01
ATC
prazosin; oral
8.3
7.7
16
20
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
7.7
145
917
A40.8
ICD-10 Finland
Other streptococcal sepsis
18.7
7.6
11
6
L01AA01
ATC
cyclophosphamide; systemic
18.7
7.6
11
6
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
18.7
7.6
11
6
I15.0
ICD-10 Finland
Renovascular hypertension
18.7
7.6
11
6
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
10.3
7.6
14
14
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
10.3
7.6
14
14
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
7.6
134
826
XQ848
NOMESCO Finland
Dermatological photography
6.2
7.5
19
32
N30.0
ICD-10 Finland
Acute cystitis
2.7
7.4
51
205
D86.0
ICD-10 Finland
Sarcoidosis of lung
7.9
7.4
16
21
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
81.4
7.4
8
*
E21.2
ICD-10 Finland
Other hyperparathyroidism
81.4
7.4
8
*
Y88.0
ICD-10 Finland
Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use
81.4
7.4
8
*
K12.10
ICD-10 Finland
Stomatitis NOS
81.4
7.4
8
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
7.4
173
1169
RJ420
NOMESCO Finland
NA
13.7
7.4
12
9
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
13.7
7.4
12
9
I42.0
ICD-10 Finland
Dilated cardiomyopathy
5.1
7.4
22
45
WX730
NOMESCO Finland
Conventional respirator
8.6
7.4
15
18
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
7.4
208
1491
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
4.3
7.3
26
64
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.9
7.3
29
79
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
6.4
7.3
18
29
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
+∞
7.3
7
*
374
Kela drug reimbursment
Ruxolitinib
+∞
7.3
7
*
1DB06
NOMESCO Finland
NA
+∞
7.3
7
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
7.3
7
*
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
+∞
7.3
7
*
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
+∞
7.3
7
*
J12.2
ICD-10 Finland
Parainfluenza virus pneumonia
+∞
7.3
7
*
RS321
NOMESCO Finland
NA
+∞
7.3
7
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
7.3
7
*
174
Kela drug reimbursment
Ruxolitinib
+∞
7.3
7
*
L01XE18
ATC
[U] ruxolitinib; oral
+∞
7.3
7
*
T83.8
ICD-10 Finland
Other complications of genitourinary prosthetic devices, implants and grafts
+∞
7.3
7
*
N165, T861
ICD-10 Finland
NA
+∞
7.3
7
*
B05D
ATC
PERITONEAL DIALYTICS
+∞
7.3
7
*
58399
ICD-8 Finland
Nephritis, unqualified
+∞
7.3
7
*
2AA01
NOMESCO Finland
NA
+∞
7.3
7
*
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
+∞
7.3
7
*
3XA02
NOMESCO Finland
NA
+∞
7.3
7
*
L04AA10
ATC
sirolimus; oral
+∞
7.3
7
*
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.4
7.3
62
281
1XC02
NOMESCO Finland
NA
16.1
7.3
11
7
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
7.3
39
135
X57
ICD-10 Finland
Unspecified privation
6.8
7.2
17
26
ZX196
NOMESCO Finland
NA
30.5
7.2
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
20.4
7.2
10
5
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
8.1
7.2
15
19
WX204
NOMESCO Finland
Axillary plexus blockaced
4.5
7.1
24
56
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
12.3
7.1
12
10
TQW11
NOMESCO Finland
Vacuum treatment of wound
12.3
7.1
12
10
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
9.0
7.1
14
16
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
7.1
105
605
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
7.0
80
415
R31
ICD-10 Finland
Unspecified haematuria
2.8
7.0
44
166
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
7.0
59
264
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
14.1
6.9
11
8
KBV10
NOMESCO Finland
Removal of stent from ureter
14.1
6.9
11
8
RJ410
NOMESCO Finland
NA
14.1
6.9
11
8
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.1
6.9
25
63
ZXC50
NOMESCO Finland
Cryotherapy
5.2
6.9
20
40
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
11.2
6.8
12
11
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
11.2
6.8
12
11
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.3
6.8
61
284
189
Kela drug reimbursment
Imatinib
40.7
6.8
8
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
40.7
6.8
8
*
JJ5AT
NOMESCO Finland
NA
40.7
6.8
8
*
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
40.7
6.8
8
*
S01AA12
ATC
tobramycin; ophthalmic
40.7
6.8
8
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
40.7
6.8
8
*
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
17.0
6.8
10
6
I50.1
ICD-10 Finland
Left ventricular failure
4.4
6.7
23
55
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
22.9
6.7
9
*
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
22.9
6.7
9
*
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
22.9
6.7
9
*
N43.3
ICD-10 Finland
Hydrocele, unspecified
6.6
6.7
16
25
XCK00
NOMESCO Finland
Perimetry
3.2
6.7
33
108
WX203
NOMESCO Finland
Infraclavicular plexus blockade
4.7
6.7
21
46
JAH00
NOMESCO Finland
Laparotomy
5.6
6.7
18
33
J01CF02
ATC
cloxacillin; systemic
6.1
6.7
17
29
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.5
6.7
29
86
FM2CE
NOMESCO Finland
NA
8.0
6.7
14
18
I35.0
ICD-10 Finland
Aortic (valve) stenosis
4.5
6.6
22
51
T89
ICPC
Diabetes insulin dependent
3.4
6.6
30
92
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
12.5
6.6
11
9
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
12.5
6.6
11
9
RS121
NOMESCO Finland
NA
12.5
6.6
11
9
H3600, E103
ICD-10 Finland
NA
8.9
6.6
13
15
L01XX05
ATC
hydroxycarbamide; oral
8.9
6.6
13
15
602
Kela drug reimbursment
Children's severe malnutrition
10.2
6.6
12
12
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.0
6.6
15
22
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
7.0
6.6
15
22
L03AA13
ATC
pegfilgrastim; parenteral
4.6
6.6
21
47
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.5
6.5
29
88
CKC12
NOMESCO Finland
Photocoagulation of retina
3.5
6.5
29
88
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
7.6
6.5
14
19
C95.9
ICD-10 Finland
Leukaemia, unspecified
70.8
6.4
7
*
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
70.8
6.4
7
*
6BCXX
NOMESCO Finland
NA
70.8
6.4
7
*
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
70.8
6.4
7
*
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
70.8
6.4
7
*
ZXE70
NOMESCO Finland
Moren than 15 and less than 18 hours
70.8
6.4
7
*
BE00A
NOMESCO Finland
NA
70.8
6.4
7
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.1
6.4
34
117
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.0
6.4
19
39
RJ421
NOMESCO Finland
NA
14.6
6.4
10
7
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
14.6
6.4
10
7
XX9XW
NOMESCO Finland
NA
14.6
6.4
10
7
H26.02
ICD-10 Finland
Presenil cataract
4.3
6.4
22
53
JAH01
NOMESCO Finland
Laparoscopy
4.3
6.4
22
53
S01BC03
ATC
diclofenac; ophthalmic
5.3
6.4
18
35
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.7
6.4
17
31
R80
ICD-10 Finland
Isolated proteinuria
11.2
6.3
11
10
ZX198
NOMESCO Finland
Other local administration
11.2
6.3
11
10
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
11.2
6.3
11
10
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
9.4
6.3
12
13
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.8
6.3
25
69
B74
ICPC
Malignant neoplasm blood other
+∞
6.3
6
*
A12AA06
ATC
calcium lactate gluconate; oral
+∞
6.3
6
*
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
6.3
6
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
6.3
6
*
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
+∞
6.3
6
*
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
+∞
6.3
6
*
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
+∞
6.3
6
*
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
6.3
6
*
1XX32
NOMESCO Finland
NA
+∞
6.3
6
*
Q61.99
ICD-10 Finland
Cystic kidney disease, unspecified
+∞
6.3
6
*
FXM00
NOMESCO Finland
Removal of extra-, para- or intracorporeal VAD
+∞
6.3
6
*
122
Kela drug reimbursment
Aplastic anaemia
+∞
6.3
6
*
D638, N189
ICD-10 Finland
NA
+∞
6.3
6
*
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
+∞
6.3
6
*
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
+∞
6.3
6
*
AK3
HP
BLTX (both lung transplants)
+∞
6.3
6
*
150
Kela drug reimbursment
Dasatinib
+∞
6.3
6
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
6.3
6
*
ZZA00
NOMESCO Finland
Split skin graft
5.2
6.2
18
36
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
27.1
6.2
8
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
5.9
6.2
16
28
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
5.9
6.2
16
28
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.8
6.2
13
17
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
7.8
6.2
13
17
B01AC04
ATC
clopidogrel; oral
2.3
6.1
57
270
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
6.1
46
195
C10AX09
ATC
ezetimibe; oral
2.5
6.1
47
203
J12.8
ICD-10 Finland
Other viral pneumonia
12.7
6.1
10
8
XX4AW
NOMESCO Finland
NA
12.7
6.1
10
8
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
12.7
6.1
10
8
R04.0
ICD-10 Finland
Epistaxis
3.1
6.1
32
110
S01ED51
ATC
timolol, combinations; ophthalmic
3.1
6.1
32
110
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.3
6.1
17
33
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
10.2
6.1
11
11
E000001
ATC
NA
1.9
6.0
93
543
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
6.0
113
701
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
5.7
6.0
16
29
Y96.9
ICD-10 Finland
Unspecified type of accident
6.2
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
213
89
43.47
318.37
2.6
1.5
u/ml
108.1
105.8
0.07
48
12
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
295
77
103.83
307.65
22.4
8.1
iu/ml
891.1
259.7
1.19
105
12
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
220
93
44.17
307.65
2.6
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
188
38
82.61
307.65
2.9
2.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
260
56
104.61
307.65
8.5
5.1
u/ml
3219.9
648.7
—
24
6
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
187
38
81.87
307.65
1.4
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
213
107
36.01
296.39
2.0
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
207
105
34.85
286.33
2.0
1.4
u/ml
277.7
267.1
0.10
155
59
(3003458) Phosphate [Moles/volume] in Serum or Plasma
339
444
25.77
285.01
38.3
6.0
mmol/l
1.2
1.0
8.61
332
414
(3048929) Epstein Barr virus Ab [Presence] in Serum
217
168
23.43
244.83
2.0
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
109
12
118.49
213.04
3.3
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
172
119
22.41
203.05
2.7
1.7
g/l
1.3
1.5
0.81
159
106
(3042733) HLA Ab [Presence] in Serum
104
15
89.13
195.77
5.6
3.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
153
89
25.18
195.70
6.7
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
152
92
24.11
190.71
6.2
1.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
162
113
21.51
189.75
13.1
6.3
mg/l
2.3
1.3
13.69
157
104
(3024471) HLA-A [Type]
101
16
80.46
187.18
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
203
218
15.80
185.05
15.9
4.0
ng/l
204.2
68.2
17.34
194
197
(3024932) HLA-DR beta [Type]
99
16
78.43
182.77
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
135
70
26.81
180.83
6.5
1.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
161
124
19.37
178.46
6.7
5.0
%
95.1
87.6
2.10
161
114
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
200
222
15.10
177.82
4.1
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
243
360
13.10
175.65
12.2
2.8
%
2.1
1.7
4.03
235
331
(3014148) Varicella zoster virus Ab [Titer] in Serum
116
46
33.31
171.66
1.2
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
137
83
23.02
170.96
7.4
8.7
u/ml
0.3
0.3
0.96
72
48
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
142
95
21.12
168.85
2.8
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
202
259
13.06
161.14
9.6
2.6
e9/l
69.9
73.5
0.49
168
194
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
115
53
28.54
160.77
1.2
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
248
418
11.62
160.17
9.9
2.1
%
24.7
24.6
0.03
229
362
(3017143) Hepatitis C virus Ab [Presence] in Serum
260
478
11.13
155.67
4.1
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
81
10
97.96
154.89
1.1
1.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
260
482
11.02
154.39
9.5
2.1
umol/l
12.3
14.3
3.76
254
451
(3023368) Bacteria identified in Blood by Culture
338
859
11.87
151.58
15.8
4.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
206
294
11.82
150.77
6.5
2.5
g/l
8.0
10.5
11.19
197
270
(3042936) Bacteria identified in Isolate by Culture
249
451
10.78
150.23
3.9
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
259
502
10.44
147.00
6.0
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
201
287
11.61
146.68
2.7
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
97
36
33.82
146.04
1.3
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
96
41
29.28
137.42
7.5
1.9
e6/l
306.2
717.9
2.54
49
14
(3026493) Urate [Moles/volume] in Serum or Plasma
334
914
10.53
136.52
10.3
2.5
umol/l
356.7
7483.1
3.73
326
802
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
99
48
25.96
134.90
6.6
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
260
551
9.48
134.48
4.2
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
95
43
27.54
132.93
6.8
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
102
57
22.67
130.73
3.4
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
70
11
74.79
128.75
6.8
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
211
371
9.61
128.07
2.7
1.7
—
—
—
0
0
(4035726)
188
289
10.27
127.74
2.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
107
71
19.30
126.25
1.9
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
199
335
9.66
125.08
20.4
4.1
mmol/l
0.3
2.0
7.35
172
275
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
155
194
11.51
123.30
21.3
4.7
mmol/l
23.2
24.3
3.93
149
180
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
91
45
24.92
122.66
3.5
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
200
356
9.13
119.17
3.5
1.9
—
—
—
0
0
(44790048)
92
50
22.71
119.03
3.5
1.9
—
—
—
0
0
(44790047)
92
50
22.71
119.03
3.5
1.9
—
—
—
0
0
(44790049)
92
50
22.71
119.03
3.5
1.9
—
—
—
0
0
(44806118)
92
50
22.71
119.03
3.5
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
200
364
8.91
116.56
3.8
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
390
1421
12.06
115.30
29.7
4.9
g/l
34.5
36.4
10.42
381
1339
(3000991) Gas panel - Venous blood
185
314
9.15
114.46
23.6
8.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
291
805
8.04
112.73
9.6
2.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
269
690
7.92
112.42
9.5
2.4
e6/l
2.8
4.9
4.57
254
614
(3011412) CD3 cells [#/volume] in Blood
85
44
23.44
112.12
8.9
2.2
e9/l
0.9
1.1
0.50
41
22
(46235355) HIV 1 and 2 tests - Meaningful Use set
269
693
7.88
111.82
4.1
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
319
974
8.32
111.43
34.8
3.8
ph
7.4
7.4
0.23
76
174
(3042111) Morphology [Interpretation] in Bone marrow Narrative
89
56
19.44
107.25
5.5
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
87
53
19.98
106.47
9.5
3.0
%
0.9
1.6
0.70
79
43
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
92
63
17.98
106.21
2.9
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
156
237
9.42
105.37
6.5
3.1
g/l
63.3
67.3
6.52
151
221
(42870588) Differential panel, method unspecified - Blood
355
1251
8.88
105.32
31.1
6.0
—
—
—
0
0
(3026782) Osmolality of Urine
255
659
7.39
104.37
10.0
2.6
mosm/kgh2o
489.5
579.0
9.33
242
565
(3017181) Myelocytes/100 leukocytes in Blood
169
285
8.76
104.28
14.0
4.8
%
0.9
0.7
0.29
116
89
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
60
13
52.88
103.48
4.2
3.9
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
76
37
24.38
102.61
9.3
2.2
e6/l
547.6
556.8
0.03
71
29
(3028026) IgM [Mass/volume] in Serum or Plasma
152
239
8.98
99.29
2.9
1.4
g/l
1.1
1.3
0.54
145
221
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
384
1521
9.94
98.89
48.3
6.2
mmol/l
1.2
1.2
0.85
376
1399
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
400
1653
11.43
98.58
60.4
6.6
mmol/l
1.2
1.2
1.60
379
1424
(3002179) Metamyelocytes/100 leukocytes in Blood
157
260
8.62
97.94
13.5
4.5
%
0.7
0.4
2.08
88
62
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
81
51
19.04
97.31
2.8
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
314
1042
7.26
96.98
12.5
2.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
346
1277
7.76
94.53
14.6
2.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
155
266
8.26
93.32
14.3
5.0
%
0.1
0.1
0.59
113
76
(3025159) Blasts/100 leukocytes in Blood
150
249
8.43
93.01
12.3
5.0
%
0.1
0.0
0.30
101
63
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
64
31
23.80
86.23
3.8
2.4
%
13.1
14.5
0.15
29
20
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
348
1370
7.20
85.87
5.2
2.3
nmol/l
75.7
73.8
0.71
340
1240
(3030467) Casts [#/volume] in Urine by Automated count
287
955
6.28
85.70
12.0
2.9
e6/l
0.1
0.5
2.99
259
717
(3002582) Erythrocytes [#/volume] in Urine
303
1058
6.39
85.59
14.0
2.9
e6/l
28.6
107.4
0.69
285
817
(3045142) Bone marrow Pathology biopsy report
66
35
21.83
85.57
2.5
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
62
29
24.53
84.68
4.8
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
163
325
7.20
84.50
6.1
2.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
281
930
6.14
84.05
11.4
2.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
50
13
43.00
82.30
10.6
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
50
13
43.00
82.30
10.6
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
50
14
39.92
80.71
10.6
1.9
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
81
5
195.70
79.94
6.5
6.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
49
14
39.02
78.63
12.9
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
51
17
33.59
78.29
10.5
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
51
17
33.59
78.29
10.5
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
51
17
33.59
78.29
10.5
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
51
17
33.59
78.29
10.5
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
63
37
19.55
77.82
9.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
63
37
19.55
77.82
9.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
63
37
19.55
77.82
9.1
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
209
565
5.92
77.76
8.7
2.7
e6/l
2.2
1.7
0.34
157
314
(21494434) Karyotype in Bone marrow
57
27
23.93
77.31
1.3
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
140
261
7.26
76.89
17.2
4.7
ph
7.4
7.4
0.18
23
25
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
63
38
19.03
76.82
1.7
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
138
254
7.32
76.72
17.0
4.8
mmol/l
1.3
1.6
0.37
113
185
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
140
263
7.20
76.28
17.3
4.7
kpa
5.0
5.2
2.62
135
249
(3014111) Lactate [Moles/volume] in Serum or Plasma
151
307
6.82
76.08
14.9
7.8
mmol/l
1.2
1.3
0.34
146
296
(3018095) Leukocytes [#/volume] in Urine
314
1226
5.85
74.98
16.2
3.4
e6/l
33.8
119.5
1.49
290
873
(40758558) Short blood count panel - Blood
264
905
5.46
73.47
32.7
6.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
251
826
5.45
73.40
5.6
2.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
389
1847
7.92
73.23
29.8
6.1
e9/l
0.0
0.0
8.45
376
1613
(3001604) Monocytes [#/volume] in Blood
388
1846
7.80
72.61
29.8
6.0
e9/l
0.6
0.6
0.35
375
1607
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
59
35
19.17
72.42
3.1
1.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
46
14
36.37
72.42
1.1
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
239
765
5.39
72.01
3.1
2.2
mg/l
3.3
3.0
1.05
215
670
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
77
9
102.43
71.49
1.1
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
49
19
28.72
71.49
4.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
176
438
5.87
71.05
5.5
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
391
1899
7.81
70.65
30.2
6.1
e9/l
1.6
2.0
6.60
380
1686
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
63
45
16.05
70.33
2.4
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
47
17
30.66
70.16
2.1
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
47
17
30.66
70.16
2.1
2.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
58
36
18.28
69.60
12.1
2.5
%
57.0
62.5
0.66
47
24
(3008757) Leukocyte morphology finding [Identifier] in Blood
64
48
15.31
69.54
15.6
2.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
48
19
28.07
69.49
4.1
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
389
1901
7.55
69.13
34.0
6.4
e9/l
0.1
0.2
7.55
379
1681
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
71
64
12.92
69.13
1.4
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
90
114
9.56
68.90
3.5
2.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
321
1339
5.56
68.88
21.4
6.7
inr
1.2
1.2
0.05
102
376
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
205
599
5.35
68.36
7.3
2.5
e6/l
0.6
1.1
0.87
153
345
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
51
25
22.80
68.03
1.6
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
93
125
9.06
67.86
2.7
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
382
1856
7.05
67.73
39.2
6.7
umol/l
9.9
11.7
4.41
375
1763
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
56
35
18.06
66.91
1.9
2.8
%
29.7
38.1
—
9
10
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
65
54
13.84
66.49
2.5
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
167
424
5.60
65.30
29.4
3.2
umol/l
6.5
8.0
0.86
161
382
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
286
1123
5.05
65.21
8.2
2.5
u/l
59.4
56.2
0.29
276
1054
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
75
80
10.99
65.14
1.9
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
134
279
6.35
65.08
6.6
2.4
ml/min/173m2
35.4
71.0
15.26
63
108
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
48
23
23.17
64.56
1.1
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
71
71
11.63
64.46
11.8
4.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
275
1063
4.91
63.57
9.9
3.2
mmol/l
2.3
2.4
3.46
258
941
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
45
19
26.13
63.54
4.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
45
19
26.13
63.54
4.3
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
52
32
18.18
62.52
1.3
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
58
46
14.27
60.85
1.8
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
50
30
18.56
60.82
6.2
6.8
%
10.6
11.8
0.92
50
30
(3037692) Legionella sp identified in Specimen by Organism specific culture
41
15
29.89
60.80
3.0
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
48
27
19.72
60.16
1.4
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
109
201
6.78
59.53
17.6
5.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
338
1585
5.19
59.41
15.1
3.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
396
2125
6.97
58.40
49.1
9.3
e9/l
3.8
4.0
0.77
386
1857
(21494814) CD8 cells/100 lymphocytes in Specimen
36
10
38.95
57.84
4.6
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
220
760
4.61
57.77
5.4
1.9
mg/l
1.7
1.1
1.74
195
565
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
48
31
17.16
56.22
2.6
2.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
42
21
21.90
55.34
8.3
4.3
%
103.7
93.8
0.47
42
21
(1616796) Gas panel - Central venous blood
64
69
10.60
54.91
10.2
2.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
62
66
10.69
53.65
2.9
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
102
195
6.43
53.43
2.0
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
58
57
11.49
53.02
12.7
3.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
45
29
17.08
52.69
11.2
2.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
53
46
12.88
52.50
7.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
53
46
12.88
52.50
7.0
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
96
177
6.58
52.09
2.7
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
53
47
12.61
51.79
7.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
53
47
12.61
51.79
7.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
53
47
12.61
51.79
7.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
53
47
12.61
51.79
7.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
63
72
9.97
51.72
1.5
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
67
83
9.27
51.72
5.9
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
335
1667
4.65
51.57
43.2
8.5
e9/l
0.0
0.0
0.88
298
1356
(3013826) Glucose [Moles/volume] in Serum or Plasma
379
2082
5.52
50.77
31.5
4.7
mmol/l
6.7
6.6
0.32
374
1945
(3004588) Protein electrophoresis panel - Serum or Plasma
98
191
6.24
50.18
7.0
2.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
224
860
4.11
49.35
6.5
3.0
ng/l
5281.0
717.0
5.26
213
709
(3019309) Folate [Moles/volume] in Red Blood Cells
168
524
4.46
49.34
2.0
1.6
nmol/l
1333.8
1176.1
0.93
147
410
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
54
7
86.78
49.12
1.9
5.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
44
31
15.58
49.12
4.3
1.5
pg
33.5
33.0
0.36
44
31
(3052851) Hemolysis interference index of Serum or Plasma
75
114
7.66
48.70
8.9
2.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
59
67
9.95
48.59
8.7
3.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
128
327
5.03
48.32
2.4
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
41
27
16.56
47.39
3.9
3.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
46
38
13.33
46.86
11.3
2.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
55
60
10.27
46.61
4.7
1.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
65
90
8.24
45.68
9.4
3.6
ratio
1.3
1.2
—
6
10
(3003694) ABO and Rh group [Type] in Blood
246
1049
3.87
45.67
2.4
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
65
91
8.15
45.25
9.4
3.7
mg/l
52.1
34.5
0.90
53
76
(3034860) Kappa light chains.free [Mass/volume] in Serum
65
91
8.15
45.25
9.4
3.7
mg/l
53.5
114.4
0.42
53
74
(3031040) Bacteria [#/volume] in Urine by Automated count
383
2224
5.18
44.96
12.2
3.6
e6/l
26.0
1154.8
0.62
13
36
(3021901) Oxygen saturation in Capillary blood
53
58
10.19
44.77
11.7
3.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
132
366
4.65
44.73
11.9
8.2
mmol/l
-0.6
1.0
3.41
112
297
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
132
367
4.63
44.56
11.9
8.1
kpa
5.0
5.1
0.88
125
353
(3027801) Oxygen [Partial pressure] in Arterial blood
132
367
4.63
44.56
11.9
8.1
kpa
11.9
12.7
0.95
125
356
(3028433) Virus identified in Specimen by Culture
34
18
20.31
43.51
1.5
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
121
330
4.61
41.63
12.8
8.6
%
94.4
96.0
1.38
115
321
(40767503) Oxygen content in Capillary blood by calculation
54
67
8.99
41.41
6.1
2.3
%
15.4
16.5
0.76
39
32
(3013727) Leukocytes other/100 leukocytes in Blood
27
10
28.61
39.51
4.1
3.4
%
47.9
53.9
—
27
10
(3006184) Hemoglobin [Mass/volume] in Capillary blood
54
71
8.48
39.48
5.4
2.4
g/l
118.6
129.5
1.86
46
56
(3025941) Bacteria identified in Stool by Culture
88
193
5.39
39.21
1.6
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
31
17
19.47
38.97
3.2
2.2
ug/l
65.3
115.3
0.53
31
17
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
68
119
6.53
38.42
10.9
2.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
185
717
3.63
38.41
2.2
1.4
nmol/l
17.1
20.3
1.56
172
620
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
36
0
+∞
38.04
4.8
0.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
36
28
13.86
37.84
1.5
9.2
—
80.8
—
0
13
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
56
81
7.73
37.73
2.1
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
421
2794
6.59
37.65
49.9
7.5
u/l
82.4
79.5
0.59
414
2641
(3012516) Albumin [Mass/volume] in Urine
228
1022
3.43
37.33
8.9
3.2
mg/l
529.2
198.3
0.57
200
644
(3007164) IgA [Mass/volume] in Serum or Plasma
197
807
3.51
37.30
2.7
1.3
g/l
2.0
2.5
2.87
164
496
(40760892) CBC W Ordered Manual Differential panel - Blood
201
841
3.46
36.67
15.9
4.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
246
1168
3.36
36.39
8.9
3.1
mmol/l
6.0
8.4
14.95
232
990
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
40
6
72.71
35.59
3.3
2.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
33
25
14.14
35.17
2.8
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
382
2421
4.30
34.65
16.8
3.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
40
8
54.50
34.06
3.5
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
191
807
3.33
33.78
7.4
3.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
27
16
17.86
32.63
2.9
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
227
1081
3.16
32.47
10.4
3.9
mg/mmol
26.3
9.3
4.99
200
681
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
108
322
4.07
32.41
8.3
2.3
u/l
48.5
175.4
0.42
97
282
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
218
1022
3.14
31.92
3.9
2.2
u/l
111.9
212.1
4.50
210
976
(3035350) Ketones [Presence] in Urine by Test strip
307
1751
3.24
31.72
11.0
3.1
estimate
0.0
0.0
0.00
83
310
(3002173) Hemoglobin [Mass/volume] in Arterial blood
105
312
4.06
31.61
13.9
8.2
g/l
104.2
124.2
19.51
98
300
(3021601) Nitrite [Presence] in Urine by Test strip
307
1758
3.21
31.36
14.5
4.4
estimate
0.0
0.0
0.00
88
326
(3009261) Glucose [Presence] in Urine by Test strip
309
1781
3.21
31.11
11.0
3.1
estimate
0.0
0.0
0.00
84
311
(21494890) Protein electrophoresis panel - 24 hour Urine
32
29
11.78
30.53
4.8
3.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
36
8
48.65
30.09
1.8
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
109
5.82
29.21
6.5
2.4
g/l
8.7
11.1
3.22
52
96
(3048879) Bone marrow aspiration report
35
8
47.20
29.11
8.1
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
244
1266
2.96
29.07
2.4
1.8
pmol/l
93.0
95.1
0.30
149
680
(40765096) Chromosome analysis panel by Banding
22
11
20.95
28.58
1.3
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
29
25
12.31
28.52
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
57
7.79
28.43
1.9
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
57
7.79
28.43
1.9
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
157
645
3.17
28.32
1.7
1.6
pmol/l
476.5
27580491.0
0.69
147
562
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
242
1264
2.92
28.25
13.8
3.8
u/l
38.0
33.0
0.52
235
1214
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
152
617
3.18
27.94
6.6
3.7
ng/l
1913.9
583.5
0.56
127
461
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
119
5.43
27.51
7.2
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
119
5.43
27.51
7.2
2.4
g/l
3.3
3.9
2.32
49
87
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
119
5.43
27.51
7.2
2.4
g/l
6.9
7.3
0.76
50
93
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
56
112
5.55
27.31
6.7
2.5
g/l
3.3
3.1
0.37
49
89
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
54
105
5.69
27.15
7.5
2.6
g/l
0.3
1.4
1.52
47
96
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
23
12.40
26.72
2.7
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
55
113
5.39
26.02
3.8
1.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
60
7.20
25.91
6.3
3.7
%
56.9
55.6
0.19
40
60
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
269
3.86
25.85
2.4
2.3
ug/l
30.4
6.8
2.38
81
244
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
69
173
4.51
25.78
14.7
9.9
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
25
20
13.16
25.67
2.5
2.4
e6/l
150.5
306.3
—
19
8
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
39
59
7.13
25.06
1.3
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
39
59
7.13
25.06
5.1
3.1
e9/l
3.5
4.1
0.93
39
59
(40768804) Tissue Pathology biopsy report
245
1347
2.74
25.02
3.4
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
21
12.53
24.92
1.6
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
30
7
45.62
24.87
1.5
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
27
26
10.97
24.67
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
27
26
10.97
24.67
1.3
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
29
7
44.10
23.90
1.4
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
22
16
14.39
23.80
1.3
1.0
miu/ml
1750.6
1352.9
0.60
22
16
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
25
23
11.43
23.52
7.2
3.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
42
74
6.14
23.32
12.9
3.1
mmol/l
2.4
2.3
0.10
32
45
(3037121) Protein [Mass/volume] in Urine
54
124
4.80
22.40
7.1
3.6
g/l
0.6
0.2
2.40
47
62
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
38
65
6.28
21.70
1.4
1.2
u/l
181.7
34.2
1.13
32
59
(3020393) Adenovirus Ag [Presence] in Stool
26
6
45.72
21.63
1.7
2.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
69
197
3.94
21.56
12.5
2.4
e6/l
0.4
0.1
0.47
69
192
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
22
19
12.11
21.50
3.0
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
84
275
3.51
21.46
9.4
3.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
181
915
2.61
21.06
12.5
3.4
estimate
0.0
0.0
0.69
77
312
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
230
1305
2.52
20.91
5.4
3.2
ng/l
88.9
37.7
0.82
196
848
(3006922) Hepatitis E virus Ab [Presence] in Serum
26
30
9.12
20.84
1.3
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
70
207
3.81
20.78
7.7
4.9
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
29
40
7.67
20.15
1.2
1.2
u/l
85.3
121.1
0.18
23
29
(40757373) Influenza virus identified in Isolate
25
7
37.63
20.03
3.2
2.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
21
19
11.53
19.90
3.1
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
19
15
13.17
19.54
4.7
1.5
—
—
—
0
0
(3019225) pH of Specimen
84
294
3.27
19.19
28.3
4.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
46
105
4.75
19.17
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
46
106
4.71
18.95
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
46
106
4.71
18.95
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
24
29
8.67
18.54
4.5
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
28
41
7.20
18.45
3.8
2.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
24
30
8.38
18.05
3.0
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
23
8
30.15
17.58
2.8
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
10
15.47
16.83
2.5
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
23
30
8.02
16.70
1.4
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
363
2689
2.62
16.57
9.9
3.9
mm/h
20.2
10.4
14.54
351
2497
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
47
124
4.11
16.26
6.2
5.0
%
1.4
1.7
1.26
40
115
(3008152) Bicarbonate [Moles/volume] in Arterial blood
62
199
3.44
16.16
12.6
7.6
mmol/l
23.2
24.4
1.55
56
186
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
117
535
2.59
16.16
4.1
2.6
mmol/l
2.4
2.4
0.14
109
466
(3022217) INR in Platelet poor plasma by Coagulation assay
89
358
2.84
15.78
27.1
16.3
inr
1.3
1.2
0.23
13
45
(3020891) Body temperature
48
133
3.91
15.52
10.1
4.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
21
9
24.36
15.24
3.0
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
15
12
12.89
15.21
1.7
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
12
12.89
15.21
2.9
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
363
2735
2.52
15.17
5.2
3.5
pmol/l
14.6
14.7
0.39
347
2500
(3012441) Differential panel - Pleural fluid
18
20
9.32
14.75
1.4
1.4
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
14
0
+∞
14.66
1.1
0.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
14
0
+∞
14.66
5.2
0.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
48
139
3.74
14.57
1.3
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
27
50
5.67
14.17
1.4
1.2
u/ml
3.8
5.3
0.27
15
18
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
57
189
3.30
14.07
2.4
3.5
pmol/l
4.1
4.7
2.58
50
168
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
44
124
3.82
13.88
1.1
1.4
miu/ml
154.5
253.2
—
9
54
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
30
63
5.02
13.74
1.1
1.1
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
13
0
+∞
13.61
1.0
0.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
17
9.71
13.51
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
13
10
13.35
13.42
2.9
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
10
13.35
13.42
24.9
5.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
13
10
13.35
13.42
24.8
5.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
28
59
4.99
12.77
4.6
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
16
9.66
12.61
3.0
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
42
123
3.66
12.53
6.6
5.0
%
0.9
0.9
0.06
36
115
(3044889) 12 lead EKG panel
337
2549
2.18
12.52
8.5
3.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
22
7.98
12.36
1.3
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
214
1380
2.02
12.25
11.5
3.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
17
8
21.99
12.09
6.6
1.1
%
171.3
123.5
—
17
8
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
39
5.87
12.06
1.3
1.3
g/l
0.4
0.3
0.16
15
25
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
39
5.87
12.06
1.3
1.3
g/l
2.6
2.6
0.02
16
25
(3027135) IgG subclass 1 [Mass/volume] in Serum
22
39
5.87
12.06
1.3
1.3
g/l
6.1
7.2
0.39
16
26
(3023199) Leukocytes [#/volume] in Pleural fluid
17
23
7.63
11.91
1.3
1.3
e6/l
10781.8
4434.1
0.31
11
14
(4062490)
22
40
5.72
11.75
1.4
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
17
9
19.55
11.66
2.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
16
7
23.60
11.64
1.3
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
28
64
4.59
11.60
1.5
1.5
g/l
0.6
0.7
0.26
22
47
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
13
10.26
11.38
1.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
101
500
2.30
11.37
2.6
2.7
ug/g
184.1
125.9
1.43
86
405
(40768797) Stomach Pathology biopsy report
97
472
2.33
11.37
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
91
431
2.38
11.34
1.4
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
16
8.99
11.17
1.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
30
75
4.21
11.12
4.1
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
17
25
7.02
11.09
2.9
2.6
nmol/l
0.7
0.8
—
10
20
(4268621)
20
36
5.76
10.79
2.4
2.1
—
—
—
0
0
(3013512) EKG study
162
983
2.00
10.69
6.0
3.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
20
7.72
10.62
1.3
1.4
e6/l
16877.8
51680.0
—
9
10
(3033799) Differential panel - Peritoneal fluid
12
12
10.24
10.48
1.3
1.7
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
10
0
+∞
10.45
2.2
0.0
%
7.6
—
—
10
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
14
6
23.99
10.29
1.3
1.2
%
96.8
90.7
—
14
6
(3037522) Nuclear Ab [Titer] in Serum
96
486
2.23
10.17
1.8
1.3
titre
351.1
492.2
0.55
27
102
(3023419) Bacteria identified in Sputum by Culture
23
50
4.79
10.11
4.0
2.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
36
5.46
9.71
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
160
997
1.92
9.58
11.6
2.8
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
19
37
5.31
9.44
1.4
1.2
titre
110.0
264.3
—
5
7
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
13
6
22.23
9.40
3.2
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
13
6
22.23
9.40
3.2
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
13
6
22.23
9.40
3.2
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
21
45
4.84
9.38
2.8
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
13
17
7.84
9.32
1.2
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
50
4.57
9.18
1.5
1.2
u/ml
1.1
6.1
—
7
17
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
9
15.99
9.08
1.6
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
21
6.84
8.94
1.7
1.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
22
52
4.39
8.75
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
32
100
3.36
8.66
3.3
1.2
mg/l
578.7
470.2
0.53
32
92
(3052592) Norovirus Ag [Presence] in Stool
13
8
16.66
8.59
1.5
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
13
8.64
8.49
4.4
1.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
8
0
+∞
8.36
1.0
0.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
108
3.21
8.30
1.9
1.3
ug/g
280.9
321.3
0.44
23
64
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
29
88
3.45
8.21
3.8
1.2
e6/l
3.3
9.0
0.79
24
69
(3045788) Cell count panel - Pleural fluid
13
20
6.66
8.10
1.2
1.4
—
—
—
0
0
(4306422)
21
51
4.27
8.08
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
17
7.22
8.03
1.5
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
11
14
8.02
8.02
1.3
1.2
u/l
17.6
14.2
0.42
11
14
(3026389) Candida sp identified in Specimen by Organism specific culture
18
39
4.76
7.94
1.1
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
62
289
2.32
7.91
12.0
3.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
24
5.98
7.90
1.4
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
50
212
2.52
7.84
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
409
3556
2.29
7.77
67.4
10.6
ml/min/173m2
61.2
86.1
36.65
380
2884
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
32
5.14
7.71
4.7
1.6
g/l
0.9
1.1
1.54
16
32
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
16
32
5.14
7.71
1.3
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
130
805
1.85
7.68
10.9
3.2
kg/l
1.0
1.0
—
10
114
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
111
3.02
7.32
1.7
1.1
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
7
0
+∞
7.31
3.3
0.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
415
3651
2.32
7.30
9.8
3.8
mmol/l
1.6
1.3
8.09
402
3403
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
427
3804
2.58
7.28
94.9
11.8
mg/l
18.5
22.5
3.75
405
2921
(3023410) Appearance of Cerebral spinal fluid
18
42
4.42
7.28
4.6
1.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
10
5
20.39
7.16
1.3
1.0
%
126.3
128.0
—
10
5
(3045414) Leukocytes [Presence] in Urine
38
147
2.73
7.15
5.2
1.6
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
13
7.84
7.14
5.0
1.2
u/l
275.5
200.8
—
10
13
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
396
3435
2.06
7.01
12.0
5.4
mmol/mol
39.8
39.5
0.24
386
3231
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
122
2.84
6.76
1.9
1.5
iu/ml
0.0
0.0
—
8
23
(3006653) Thiamine [Moles/volume] in Blood
10
14
7.28
6.72
1.0
1.2
nmol/l
135.4
160.8
—
10
14
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
9
12.48
6.61
5.1
3.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
33
4.66
6.50
1.3
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
18
46
4.03
6.50
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
390
3394
1.95
6.41
6.2
4.1
mu/l
2.0
2.2
0.32
379
3124
(3000492) Spirometry study
74
403
2.00
6.34
2.9
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
12
22
5.57
6.32
2.6
1.7
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
6
0
+∞
6.26
5.7
0.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
6
0
+∞
6.26
6.7
0.0
e6/l
1909.7
—
—
6
0
(21494755) Public health laboratory ask at order entry panel
15
487
0.28
6.08
1.3
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
35
4.40
6.07
1.3
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
19
54
3.63
5.94
2.3
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
32
126
2.65
5.84
1.5
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
406
0.25
5.57
1.1
1.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
29
4.58
5.54
1.3
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
12
25
4.90
5.52
1.1
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
317
2646
1.63
5.50
4.2
3.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
26
95
2.84
5.46
9.3
7.0
mmol/l
1.2
1.3
0.61
19
80
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
267
0.21
5.41
1.0
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
9
8
11.44
5.31
5.7
1.9
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
9
8
11.44
5.31
11.1
2.3
mmol/l
1.2
1.2
—
9
8
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
80
2.97
5.27
1.9
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
16
44
3.73
5.25
1.6
1.5
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
5
0
+∞
5.22
8.0
0.0
ug/l
7.2
—
—
5
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
320
2695
1.61
5.18
11.7
3.3
u/l
75.9
47.5
2.47
312
2553
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
418
3792
2.05
5.12
8.7
4.3
mmol/l
4.5
4.7
4.95
406
3561
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
124
2.52
4.99
1.6
2.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
15
41
3.75
4.96
1.3
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
27
107
2.62
4.89
8.8
4.2
mmol/l
4.3
3.9
2.20
22
98
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
20
67
3.07
4.89
1.2
1.0
iu/ml
36.0
14.9
—
7
9
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
416
3780
1.99
4.88
8.3
4.2
mmol/l
1.4
1.4
0.82
402
3529
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
56
310
1.92
4.56
2.7
4.9
ug/l
2.9
20.9
0.71
44
253
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
60
3.08
4.44
1.7
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
419
3845
1.94
4.34
8.4
4.7
mmol/l
2.6
2.8
8.89
407
3582
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
31
3.95
4.28
1.8
1.5
u/l
3.8
5.2
—
6
16
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
37
3.59
4.08
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
10
8.12
4.07
1.3
1.0
%
86.9
97.4
—
8
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
10
8.12
4.07
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
234
1.97
4.04
3.8
3.0
e9/l
3.5
4.1
0.77
34
197
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
53
3.09
4.00
1.7
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
38
3.49
3.93
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
11
7.38
3.87
7.8
3.7
—
—
—
0
0
(3035880) pH of Pleural fluid
8
11
7.38
3.87
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
22
89
2.55
3.85
1.5
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
8
8.86
3.78
1.0
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
19
72
2.71
3.78
11.2
6.9
mmol/l
12.1
11.3
0.30
14
65
(3018572) Chloride [Moles/volume] in Blood
19
72
2.71
3.78
11.2
6.9
mmol/l
105.1
105.3
0.09
14
65
(3049717) Cytology report of Urine Cyto stain
28
129
2.25
3.72
2.1
2.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
16
5.71
3.67
1.1
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
16
5.71
3.67
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
30
3.73
3.66
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
30
3.73
3.66
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
30
3.73
3.66
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
30
3.73
3.66
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
30
3.73
3.66
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
30
3.73
3.66
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
35
3.49
3.64
2.3
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
198
0.24
3.62
1.4
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
113
1516
0.66
3.52
4.2
2.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
41
3.23
3.52
4.8
4.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
41
226
1.89
3.41
1.2
1.2
u/ml
83.2
290.7
1.23
35
209
(3022689) Creatine [Moles/volume] in Urine
7
10
7.09
3.37
4.7
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
71
462
1.63
3.35
5.3
4.2
%
29.5
30.7
0.43
64
318
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
7
8.66
3.27
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
7
8.66
3.27
1.0
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
27
131
2.13
3.19
1.6
1.9
pmol/l
201.4
230.9
0.80
27
123
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
111
2.23
3.18
1.1
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
80
2.43
3.10
2.6
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
33
175
1.95
3.09
1.7
1.8
nmol/l
44.8
38.1
0.58
33
166
(3017569) Oxygen content in Arterial blood
7
12
5.90
3.03
1.4
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
81
2.40
3.02
2.6
1.1
—
—
—
0
0
(1002224) Polysomnography panel
6
192
0.30
3.02
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
22
4.15
2.89
1.8
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
77
2.39
2.85
1.6
1.6
e6/l
8217.2
10613.9
—
10
61
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
18
4.50
2.80
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
10
6.06
2.70
4.5
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
10
6.06
2.70
1.5
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
61
404
1.59
2.69
1.4
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
148
1.95
2.67
1.6
1.4
iu/l
22.1
22.2
0.00
20
120
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
33
3.08
2.54
2.1
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
75
2.31
2.54
1.2
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
16
4.42
2.48
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
102
769
1.42
2.41
1.7
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
12
5.05
2.41
1.5
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
12
5.05
2.41
1.5
3.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
118
2.00
2.40
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
17
4.16
2.37
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
61
418
1.53
2.33
19.6
6.9
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
8
23
3.52
2.28
1.7
1.3
mmol/l
23.3
32.0
—
8
23
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
93
2.09
2.24
1.8
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
26
3.11
2.02
1.3
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
21
3.37
1.97
1.3
1.1
iu/ml
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
39
2.60
1.93
1.3
1.4
nmol/l
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
432
1.45
1.83
1.7
1.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
5
12
4.20
1.83
8.0
6.5
mmol/l
25.6
24.8
—
5
12
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
41
2.47
1.76
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
113
912
1.32
1.72
1.4
1.3
u/ml
3.5
1.5
0.32
33
266
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
46
0.00
1.71
0.0
1.6
—
—
—
0
0
(4281824)
8
31
2.61
1.66
1.1
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
76
2.01
1.66
1.0
1.1
—
12.3
—
0
8
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
173
1484
1.26
1.64
4.0
4.3
ug/l
2.4
2.2
0.10
162
1356
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
14
3.60
1.62
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
14
3.60
1.62
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
63
2.09
1.61
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
421
4040
1.46
1.57
70.4
11.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
15
3.36
1.52
1.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
15
3.36
1.52
1.2
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
6
21
2.88
1.51
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
66
2.00
1.44
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
40
2.27
1.41
1.4
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
381
3616
1.30
1.38
83.3
12.9
%
34.2
40.9
48.38
316
2794
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
42
2.17
1.34
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
54
2.06
1.34
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
48
2.11
1.28
1.4
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
35
2.31
1.27
1.3
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
8
36
2.24
1.25
1.3
1.1
mg/l
375.0
251.4
—
8
31
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
8
36
2.24
1.25
1.3
1.1
mg/l
50.9
37.8
—
8
27
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
172
1.54
1.23
3.4
2.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
223
0.57
1.19
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
33
234
1.44
1.14
1.1
1.2
iu/ml
88.7
126.5
0.36
11
88
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
219
0.58
1.12
1.5
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
218
0.58
1.10
1.5
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
215
0.59
1.05
1.5
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
215
0.59
1.05
1.5
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
25
171
1.49
1.04
8.8
2.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
46
1.98
1.04
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
93
1.63
0.95
6.4
3.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
63
1.76
0.91
2.1
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
103
0.48
0.90
1.2
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
381
3666
1.22
0.89
10.5
4.2
mmol/l
6.1
5.9
0.97
362
3394
(3016879) Cocaine [Presence] in Urine
13
203
0.63
0.86
1.5
2.2
—
—
—
0
0
(4027681)
6
32
1.89
0.82
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
404
1.27
0.80
1.3
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
33
1.83
0.79
2.2
1.6
ug/l
17.5
17.6
—
6
33
(3015183) Erythrocyte sedimentation rate
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
83
1.58
0.75
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
172
0.63
0.75
1.5
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
37
465
0.78
0.74
1.6
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
43
1.64
0.67
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
150
0.66
0.59
2.1
3.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
218
0.72
0.57
1.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
65
1.55
0.56
1.6
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
7
45
1.56
0.49
1.4
1.2
pmol/l
26.5
46.1
—
7
12
(3041354) Potassium [Moles/volume] in Venous blood
7
45
1.56
0.49
2.1
2.9
mmol/l
4.1
4.1
—
7
45
(4034850)
9
131
0.68
0.43
13.9
8.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
8.9
—
0
15
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
42
484
0.85
0.40
1.8
2.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
18
0.00
0.40
0.0
1.7
—
8.5
—
0
11
(4010399)
32
273
1.18
0.36
3.6
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
6
43
1.40
0.35
2.7
4.1
—
19.4
—
0
13
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
445
0.87
0.34
1.7
1.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
44
1.37
0.34
2.3
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
16
127
1.27
0.34
1.8
1.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
45
1.34
0.34
2.3
2.9
mmol/l
109.0
105.2
—
6
45
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
111
1.27
0.30
1.9
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
12
94
1.28
0.28
1.3
1.2
—
38.5
—
0
8
(3014051) Protein [Presence] in Urine by Test strip
9
77
1.17
0.24
7.7
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
39
1.29
0.23
1.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
95
0.73
0.22
2.0
1.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
29.5
—
0
11
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(4133840)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
109.6
—
0
14
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
81
857
0.93
0.20
2.5
2.8
ug/l
0.9
0.7
0.94
62
529
(3008898) HLA-B27 [Presence]
14
159
0.88
0.13
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
31
330
0.94
0.10
1.1
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
45
1.11
0.10
1.8
3.6
u/ml
14.0
37.2
—
5
45
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
165
0.91
0.09
1.7
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
57
590
0.96
0.07
2.8
1.9
%
1.5
1.5
0.23
49
536
(3022621) pH of Urine by Test strip
25
235
1.07
0.07
8.1
2.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
80
0.87
0.07
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
187
1.07
0.06
1.8
2.1
—
—
—
0
0
(4094501)
9
103
0.87
0.06
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
104
0.86
0.06
1.2
3.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
60
587
1.03
0.04
1.2
1.2
u/ml
13.6
11.8
0.05
24
239
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
230
1.05
0.03
2.0
2.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
119
1188
1.00
0.00
3.7
3.8
%
23.8
21.0
0.92
59
513
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
61
609
1.00
0.00
1.3
1.2
iu/ml
48.4
37.5
0.16
22
191
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
6.6
—
0
7
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
2.1
—
0
6
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
73
0.96
0.00
1.1
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_FAILU_REJEC_TRANSPLANTED_ORGANS_TISSU – Failure and rejection of transplanted organs and tissues
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).